Number of participants with abnormal results in biochemistry parameters (alanine aminotransferase, albumin, alkaline phosphatase, aspartate aminotransferase, bilirubin, blood urea nitrogen, creatinine, total protein).;Number of participants with abnormal results in coagulation parameters (activated partial thromboplastin, prothrombin time).;Number of participants with abnormal results in hematology parameters (hemoglobin, platelet count, red blood cell count, total and differential white blood cell count).;Number of participants with local and systemic adverse events (AEs) after vaccination with SCB-2020S vaccine.;Number of participants with MAAEs, SAEs, AESIs and AEs leading to discontinuation from study.;Number of participants with unsolicited AEs after vacccination with SCB-2020S vaccine

Number of participants with abnormal results in biochemistry parameters (alanine aminotransferase, albumin, alkaline phosphatase, aspartate aminotransferase, bilirubin, blood urea nitrogen, creatinine, total protein).;Number of participants with abnormal results in coagulation parameters (activated partial thromboplastin, prothrombin time).;Number of participants with abnormal results in hematology parameters (hemoglobin, platelet count, red blood cell count, total and differential white blood cell count).;Number of participants with local and systemic adverse events (AEs) after vaccination with SCB-2020S vaccine.;Number of participants with MAAEs, SAEs, AESIs and AEs leading to discontinuation from study.;Number of participants with unsolicited AEs after vacccination with SCB-2020S vaccine